Science Explorer Interactive view Map
Company · Jiangyin · China

Biortus (China)

Research works
24
▼ 8% vs 2013–17
Citations
529
22.4 per fractional work
Top-10% rate
22.1%
record average 16.5%
Open access
62%
world 28%

Not ranked overall: Biortus (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.67× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.46× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.11× its world share, 0 worksImmunology and Micro…Chemistry: 1.07× its world share, 0 worksChemistryEnergy: 1.35× its world share, 0 worksEnergyEngineering: 0.29× its world share, 0 worksEngineeringMaterials Science: 0.80× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.51× its world share, 0 worksPhysics and AstronomyDentistry: 0.87× its world share, 0 worksDentistryMedicine: 2.18× its world share, 4 worksMedicineNursing: 9.59× its world share, 0 worksNursingVeterinary: 8.27× its world share, 0 worksVeterinaryworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Nursing, 9.6×. Every wedge is a field page.

Which keywords describe research at Biortus (China)?

By fractional works in all years, weighted toward what it does more of than the world: Biosensors, Microfluidic Devices, Breast Cancer, CDK4/6 Inhibitors, Tissue Engineering, Bioinks, Bioprinting and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 8 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 8 words, with their numbers
  1. Epidemiology2▲ 1.71×13 topics
  2. Biosensors1▲ 9.0×4 topics
  3. Breast Cancer1▲ 18×1 topic
  4. CDK4/6 Inhibitors1▲ 311×1 topic
  5. Microfluidic Devices1▲ 61×2 topics
  6. Tissue Engineering1▲ 9.2×2 topics
  7. Bioinks1▲ 93×1 topic
  8. Bioprinting1▲ 93×1 topic

Which research topics does Biortus (China) publish most on?

By volume in 2022–2025: Advanced Breast Cancer Therapies, Probiotics and Fermented Foods, Gut microbiota and health and Drug Transport and Resistance Mechanisms.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  2. 2 Probiotics and Fermented Foods Food Science 0 works
  3. 3 Gut microbiota and health Molecular Biology 0 works
  4. 4 Drug Transport and Resistance Mechanisms Oncology 0 works
  5. 5 CAR-T cell therapy research Oncology 0 works
  6. 6 Food composition and properties Nutrition and Dietetics 0 works
  7. 7 Polysaccharides Composition and Applications Food Science 0 works
  8. 8 Cancer-related Molecular Pathways Oncology 0 works
  9. 9 Microtubule and mitosis dynamics Cell Biology 0 works
  10. 10 Cancer Research and Treatments Biotechnology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.2%not open37.8%

World: 28% of research is openly available.

with international co-authors34.2%domestic only65.8%

World: 19% is written across borders.

How has Biortus (China)'s research output changed?

Output in 2018–2022 was 8% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Jiangyin

All research institutions in Jiangyin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.